望远镜放大疗法治疗弱视的有效性:一项初步研究。
Effectiveness of telescopic magnification in the treatment of amblyopia: a pilot study.
作者信息
Wu Johnny, Nazemi Fariba, Schofield Jennifer, Mirabella Giuseppe, Wong Agnes M F
机构信息
FRCSC, Department of Ophthalmology and Vision Sciences, The Hospital for Sick Children, 555 University Ave, Toronto, ON M5G 1X8, Canada.
出版信息
Arch Ophthalmol. 2010 Mar;128(3):297-302. doi: 10.1001/archophthalmol.2009.400.
OBJECTIVE
To compare the effectiveness of patching plus telescopic magnification vs patching alone in treating refractory amblyopia.
METHODS
Children aged 4 to 17 years who failed previous amblyopia treatment were recruited into this prospective study. Subjects were randomly assigned to either 30 minutes per day of patching of the fellow eye only (n = 7) or 30 minutes per day of patching of the fellow eye plus concurrent use of a telescope in the amblyopic eye (n = 8).
MAIN OUTCOME MEASURE
Best-corrected logMAR visual acuity score of the amblyopic eye after 17 weeks of treatment.
RESULTS
Both treatment groups demonstrated significant improvement in visual acuity in the amblyopic eye after 17 weeks (P = .001). Improvements in the patching-only group were slightly greater over the course of treatment, but this difference was not statistically significant (P = .06). At 17 weeks, mean visual acuity improvement from baseline was 0.14 logMAR (SD, 0.13 logMAR) in the patching-only group and 0.06 logMAR (SD, 0.17 logMAR) in the patching plus telescope group (P = .11). The 17-week visual acuity was at least 0.2 logMAR and/or improved from baseline by at least 0.2 logMAR in 2 patients in the patching-only group and none in the patching plus telescope group (P = .08).
CONCLUSION
Treatment of refractory amblyopia in children using telescopic magnification did not appear to confer any additional benefits over patching alone.
APPLICATION TO CLINICAL PRACTICE
Occlusion and penalization remain the standard of care for patients with amblyopia and should remain the benchmark against which other treatments are compared in clinical trials for amblyopia therapy.
TRIAL REGISTRATION
clinicaltrials.gov Identifier: NCT00970554.
目的
比较眼罩遮盖联合望远镜放大与单纯眼罩遮盖治疗难治性弱视的效果。
方法
招募4至17岁先前弱视治疗失败的儿童参与这项前瞻性研究。受试者被随机分配至以下两组:仅对健眼每天进行30分钟眼罩遮盖(n = 7)或对健眼每天进行30分钟眼罩遮盖并同时对弱视眼使用望远镜(n = 8)。
主要观察指标
治疗17周后弱视眼的最佳矫正logMAR视力评分。
结果
两个治疗组在治疗17周后弱视眼视力均有显著改善(P = .001)。在治疗过程中,单纯眼罩遮盖组的视力改善略大,但这种差异无统计学意义(P = .06)。在17周时,单纯眼罩遮盖组从基线的平均视力改善为0.14 logMAR(标准差,0.13 logMAR),眼罩遮盖联合望远镜组为0.06 logMAR(标准差,0.17 logMAR)(P = .11)。单纯眼罩遮盖组有2例患者17周时视力至少提高0.2 logMAR和/或较基线提高至少0.2 logMAR,眼罩遮盖联合望远镜组无患者达到此标准(P = .08)。
结论
对于儿童难治性弱视,使用望远镜放大治疗似乎并未比单纯眼罩遮盖带来更多益处。
临床实践应用
遮盖和压抑疗法仍然是弱视患者的标准治疗方法,并且应始终作为弱视治疗临床试验中其他治疗方法比较的基准。
试验注册
clinicaltrials.gov标识符:NCT00970554。